{"id":815061,"date":"2025-02-19T16:18:38","date_gmt":"2025-02-19T21:18:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/"},"modified":"2025-02-19T16:18:38","modified_gmt":"2025-02-19T21:18:38","slug":"neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/","title":{"rendered":"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MOUNTAIN VIEW, Calif., Feb.  19, 2025  (GLOBE NEWSWIRE) &#8212; NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year of 2024 after market close on Tuesday, March 4, 2025. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time.<\/p>\n<p align=\"justify\">Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YK3xZoonoytNx0rj5EiAgB5MCSBKkgLtosd3pMoxAXXLc4wHChr9uT9U2rGt7uDYANacWnQslLnNwJXNx6cimBPnZLW7snZULpcjaOdUN60eRS21ZYCajxo9bWW-IO-778i3aEVrxzuF_6hPBqk3wnc4m9VaQIFJaAdUaHZ2ybrDv53FbqAntG8JR8Tv-QtnIZJ1x4ukgnSebzvhV3MfL0suig46eR-NkzQ4F9-2GlU=\" rel=\"nofollow\" target=\"_blank\">https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1706647&amp;tp_key=43fdbb668b<\/a>. Individuals interested in participating in the call via telephone may access the call by dialing +1-877-407-3982 and referencing Conference ID 13751530. The webcast will be archived on the company\u2019s investor relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YK3xZoonoytNx0rj5EiAgNvG8Tf0u7XeBCGSzxmkhaD-AOaLd55rCfzbt8oeR4jFvmmSHEQ2PWZHU9IKkFPNYLIfQYKmgLGECFzgAbYgBfmxcaI7j_nPUt3DLB91tp4V2OUR4eUppRdV6TgcY6-na-J1oJeCqKzG-3P--yTxvTY5emX6jqPVmdRAxtiqoSyH\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.neuropace.com\/news-and-events\/events<\/a> and will be available for replay for at least 90 days after the event.<\/p>\n<p align=\"justify\">\n        <strong>About NeuroPace, Inc. <\/strong><br \/>\n        <br \/>Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Jeremy Feffer <br \/>Managing Director <br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wrXZFl_kIs8Miy3Wz8mPptoQsU1d00V3a2WBUD8uG4b3pLsuLc-ntQnOHx-O4d0xL-76l3xmCKyByugFHMCwQYOZ_4KbH0FdmkOqKwYZ0C_3tes0yX14zbIjnWnC0zyp\" rel=\"nofollow\" target=\"_blank\">jfeffer@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWEwNmI3NjAtMjA0ZS00ODQ2LTlmN2UtMjRhZWI4YjY5NjFiLTEyMTgwODg=\/tiny\/NeuroPace-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MOUNTAIN VIEW, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year of 2024 after market close on Tuesday, March 4, 2025. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1706647&amp;tp_key=43fdbb668b. Individuals interested in participating in the call via telephone may access the call by dialing +1-877-407-3982 and referencing Conference ID 13751530. The webcast will be archived &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815061","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MOUNTAIN VIEW, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year of 2024 after market close on Tuesday, March 4, 2025. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1706647&amp;tp_key=43fdbb668b. Individuals interested in participating in the call via telephone may access the call by dialing +1-877-407-3982 and referencing Conference ID 13751530. The webcast will be archived &hellip; Continue reading &quot;NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-19T21:18:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025\",\"datePublished\":\"2025-02-19T21:18:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/\",\"name\":\"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU=\",\"datePublished\":\"2025-02-19T21:18:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/","og_locale":"en_US","og_type":"article","og_title":"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Market Newsdesk","og_description":"MOUNTAIN VIEW, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year of 2024 after market close on Tuesday, March 4, 2025. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1706647&amp;tp_key=43fdbb668b. Individuals interested in participating in the call via telephone may access the call by dialing +1-877-407-3982 and referencing Conference ID 13751530. The webcast will be archived &hellip; Continue reading \"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-19T21:18:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025","datePublished":"2025-02-19T21:18:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/","name":"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU=","datePublished":"2025-02-19T21:18:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA0MCM2NzUwODQ1IzIyMDY1MzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neuropace-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815061","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815061"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815061\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815061"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815061"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}